Adjuvant therapy for breast cancer: who should get what?
Chew
H K
HK
Division of Hematology/Oncology, University of California-Davis, Sacramento, CA 95817, USA. helen.chew@ucdmc.ucdavis.edu
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000379:methods; D005260:Female; D006801:Humans; D018579:Patient Selection; D011379:Prognosis; D018714:Radiotherapy, Adjuvant / Q000379:methods; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
D013629:Tamoxifen